← Back to Screener
Polyrizon Ltd. Ordinary Shares (PLRZ)
Price$12.99
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)296.75%
Price vs S&P 500 (4W)-20.49%
VGM Score63.84
Market Capitalization$23.16M
All Metrics
Book Value / Share (Quarterly)$13.05
P/TBV (Annual)0.73x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-2.82
Price vs S&P 500 (YTD)44.85%
EPS (TTM)$-5.64
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-5.64
EPS (Annual)$-4.90
ROI (Annual)-15.89%
Cash / Share (Quarterly)$7.75
ROA (Last FY)-15.56%
EBITD / Share (TTM)$-18.23
Cash Flow / Share (Annual)$-2.82
P/B Ratio1.10x
P/B Ratio (Quarterly)0.64x
Net Income / Employee (Annual)$-3,335,000
Net Interest Coverage (TTM)-5.44x
ROA (TTM)-17.48%
EPS Incl Extra (Annual)$-4.90
Current Ratio (Annual)29.03x
Quick Ratio (Quarterly)29.03x
3-Month Avg Trading Volume0.05M
52-Week Price Return155.71%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$11.47
52-Week High$18.20
EPS Excl Extra (Annual)$-4.90
26-Week Price Return304.67%
Quick Ratio (Annual)29.03x
13-Week Price Return-4.56%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)29.03x
Enterprise Value$21.85M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$7.75
3-Month Return Std Dev104.45%
Net Income / Employee (TTM)$-3,512,000
ROE (Last FY)-15.89%
EPS Basic Excl Extra (Annual)$-4.90
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-5.64
ROI (TTM)-17.84%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$11.47
Price vs S&P 500 (52W)131.34%
Year-to-Date Return53.00%
5-Day Price Return-15.70%
EPS Normalized (Annual)$-4.90
ROA (5Y Avg)-79.38%
Month-to-Date Return-24.34%
EBITD / Share (Annual)$-8.74
EPS Basic Excl Extra (TTM)$-5.64
P/TBV (Quarterly)0.73x
P/B Ratio (Annual)0.64x
Book Value / Share (Annual)$13.05
Price vs S&P 500 (13W)-12.81%
Beta0.08x
Revenue / Share (TTM)$0.00
ROE (TTM)-17.84%
52-Week Low$2.88
mGradeB
vgmGradeB
Show chart for
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PLRZPolyrizon Ltd. Ordinary Shares | — | — | B | $12.99 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Polyrizon Ltd is a clinical-stage biotech company developing nasal gel treatments designed to provide preventative protection against viruses including COVID-19 variants, influenza, and allergens. The company's proprietary platforms—Capture & Contain and Trap & Target—deliver broad-spectrum respiratory pathogen defense.